Current tools for the detection and diagnosis of HCC include radiographic assessments (ultrasound for screening, computed tomography, and magnetic resonance imaging for diagnosis), and serum biomarkers (alpha-fetoprotein—AFP) [110]. Here, AFP is linked to hepatocellular carcinoma.